Commercialization by a Third Party. The University and the Member will have a negotiated share subject to the terms of the agreement with the third party, and the relative shares of the University and the Member will be commensurate with the past and expected costs and efforts of each of them in participating in commercialization by the third party.
Commercialization by a Third Party. The University shall have a negotiated share subject to the terms of the agreement with the Third Party. Normally the Employee shall not receive less than a 50 percent share of net revenues.
Commercialization by a Third Party. If in the Injection Product Election is that Toray is given responsibility for Commercialization of Injection Products in Europe, then Toray shall diligently proceed to negotiate and enter into one or more binding exclusive license agreements with Third Party Commercialization partners (each such partner a “European Partner”, and each such agreement a “European License”) in accordance with this Section 3.3. For clarity, consistent with Section 15.4 below, Toray shall not have the authority to bind Acologix to any European License or any other obligations, but it shall have the right to grant an exclusive license to one or more European Partners in accordance with this Section 3.3 and Section 5.1. [***] *** Confidential treatment request pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. Omitted portions have been filed separately with the Commission.
